Form 8-K - Current report:
SEC Accession No. 0001493152-25-005830
Filing Date
2025-02-11
Accepted
2025-02-11 10:32:39
Documents
39
Period of Report
2025-02-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38582
2 ex99-1.htm EX-99.1 20455
3 ex99-1_001.jpg GRAPHIC 376933
4 ex99-1_002.jpg GRAPHIC 689079
5 ex99-1_003.jpg GRAPHIC 366909
6 ex99-1_004.jpg GRAPHIC 221273
7 ex99-1_005.jpg GRAPHIC 391044
8 ex99-1_006.jpg GRAPHIC 303443
9 ex99-1_007.jpg GRAPHIC 400136
10 ex99-1_008.jpg GRAPHIC 433899
11 ex99-1_009.jpg GRAPHIC 459246
12 ex99-1_010.jpg GRAPHIC 236275
13 ex99-1_011.jpg GRAPHIC 316304
14 ex99-1_012.jpg GRAPHIC 341175
15 ex99-1_013.jpg GRAPHIC 339084
16 ex99-1_014.jpg GRAPHIC 319460
17 ex99-1_015.jpg GRAPHIC 276379
18 ex99-1_018.jpg GRAPHIC 353933
19 ex99-1_019.jpg GRAPHIC 268899
20 ex99-1_020.jpg GRAPHIC 284868
21 ex99-1_021.jpg GRAPHIC 277390
22 ex99-1_022.jpg GRAPHIC 361128
23 ex99-1_023.jpg GRAPHIC 335907
24 ex99-1_024.jpg GRAPHIC 370729
25 ex99-1_025.jpg GRAPHIC 367467
26 ex99-1_026.jpg GRAPHIC 285397
27 ex99-1_027.jpg GRAPHIC 395359
  Complete submission text file 0001493152-25-005830.txt   12318090

Data Files

Seq Description Document Type Size
28 XBRL SCHEMA FILE pcsa-20250211.xsd EX-101.SCH 3060
29 XBRL LABEL FILE pcsa-20250211_lab.xml EX-101.LAB 34240
30 XBRL PRESENTATION FILE pcsa-20250211_pre.xml EX-101.PRE 22389
41 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3691
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 25608111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)